Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT GlobeNewswire July 31, 2025 SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced […]